Synonym
PSB-12062; PSB12062; PSB 12062; N-(p-Methylphenylsulfonyl)phenoxazine
IUPAC/Chemical Name
10-tosyl-10H-phenoxazine
InChi Key
DHZNMEIBMACSFH-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H15NO3S/c1-14-10-12-15(13-11-14)24(21,22)20-16-6-2-4-8-18(16)23-19-9-5-3-7-17(19)20/h2-13H,1H3
SMILES Code
O=S(N1C2=C(C=CC=C2)OC3=CC=CC=C13)(C4=CC=C(C)C=C4)=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 -4 C for short term (days to weeks) or -20 C for long term(months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
337.39
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Imraish A, Abu-Thiab T, Hammad H. P2X and P2Y receptor antagonists
reduce inflammation in ATP-induced microglia. Pharm Pract (Granada). 2023 Jan-
Mar;21(1):2788. doi: 10.18549/PharmPract.2023.1.2788. Epub 2022 Jan 5. PMID:
37090457; PMCID: PMC10117305.
2: Stokes L, Layhadi JA, Bibic L, Dhuna K, Fountain SJ. P2X4 Receptor Function
in the Nervous System and Current Breakthroughs in Pharmacology. Front
Pharmacol. 2017 May 23;8:291. doi: 10.3389/fphar.2017.00291. PMID: 28588493;
PMCID: PMC5441391.
3: Orriss IR, Davies BK, Bourne LE, Arnett TR. Modulation of osteoblast
differentiation and function by the P2X4 receptor. Purinergic Signal. 2023
Jun;19(2):367-378. doi: 10.1007/s11302-022-09887-x. Epub 2022 Aug 17. PMID:
35976527; PMCID: PMC10247667.
4: Fortuny-Gomez A, Fountain SJ. Pharmacological differences between human and
mouse P2X4 receptor explored using old and new tools. Purinergic Signal. 2024
Dec;20(6):659-667. doi: 10.1007/s11302-024-10018-x. Epub 2024 May 20. PMID:
38767821; PMCID: PMC11554605.
5: Hernandez-Olmos V, Abdelrahman A, El-Tayeb A, Freudendahl D, Weinhausen S,
Müller CE. N-substituted phenoxazine and acridone derivatives: structure-
activity relationships of potent P2X4 receptor antagonists. J Med Chem. 2012 Nov
26;55(22):9576-88. doi: 10.1021/jm300845v. Epub 2012 Nov 1. PMID: 23075067.
6: Xiang Z, Jiang X, Ji R, Yuan H. Enhanced expression of P2X4 purinoceptors in
pyramidal neurons of the rat hippocampal CA1 region may be involved ischemia-
reperfusion injury. Purinergic Signal. 2021 Sep;17(3):425-438. doi:
10.1007/s11302-021-09780-z. Epub 2021 May 9. PMID: 33966147; PMCID: PMC8410916.
7: Layhadi JA, Fountain SJ. P2X4 Receptor-Dependent Ca2+ Influx in
Model Human Monocytes and Macrophages. Int J Mol Sci. 2017 Oct 27;18(11):2261.
doi: 10.3390/ijms18112261. PMID: 29077063; PMCID: PMC5713231.
8: Layhadi JA, Turner J, Crossman D, Fountain SJ. ATP Evokes Ca2+
Responses and CXCL5 Secretion via P2X4 Receptor Activation in Human
Monocyte-Derived Macrophages. J Immunol. 2018 Feb 1;200(3):1159-1168. doi:
10.4049/jimmunol.1700965. Epub 2017 Dec 18. PMID: 29255078; PMCID: PMC5784824.
9: Wildner F, Neuhäusel TS, Klemz A, Kovács R, Ulmann L, Geiger JRP, Gerevich Z.
Extracellular ATP inhibits excitatory synaptic input on parvalbumin positive
interneurons and attenuates gamma oscillations via P2X4 receptors. Br J
Pharmacol. 2024 Jun;181(11):1635-1653. doi: 10.1111/bph.16298. Epub 2024 Jan 31.
PMID: 38073073.
10: He J, Zhou Y, Arredondo Carrera HM, Sprules A, Neagu R, Zarkesh SA, Eaton C,
Luo J, Gartland A, Wang N. Inhibiting the P2X4 Receptor Suppresses Prostate
Cancer Growth In Vitro and In Vivo, Suggesting a Potential Clinical Target.
Cells. 2020 Nov 20;9(11):2511. doi: 10.3390/cells9112511. PMID: 33233569; PMCID:
PMC7699771.
